The utility of thromboelastography in inherited and acquired bleeding disorders

British Journal of Haematology

Volumn 174, Issue 4, 2016, Pages 503-514

  Nogami, Keiji ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

bleeding disorders; haemophilia; monitoring; thromboelastography

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLEEDING DISORDER; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD EXAMINATION; DIAGNOSTIC VALUE; DRUG EFFICACY; HEART SURGERY; HEMOPHILIA; HEMOSTASIS; HUMAN; INJURY; LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; RARE DISEASE; REVIEW; ROTATIONAL THROMBOELASTOMETRY; THROMBOELASTOGRAPHY; VISCOELASTICITY;

EID: 84982933530     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14148     Document Type: Review

References (85)

1. Afshari, A., Wikkelsø, A., Brok, J., Møller, A.M. & Wetterslev, J. (2011) Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database of Systematic Reviews, 16, CD007871.
2. Al Hawaj, M.A., Martin, E.J., Venitz, J., Barrett, J.C., Kuhn, J.G., Nolte, M.E. & Brophy, D.F. (2013) Monitoring rFVIII prophylaxis dosing using global haemostasis assays. Haemophilia, 19, 409–414.
3. Aledort, L.M., Haschmeyer, R.H. & Pettersson, H. (1994) A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. Journal of Internal Medicine, 236, 391–399.
4. Astermark, J., Donfield, S.M., DiMichele, D.M., Gringeri, A., Gilbert, S.A., Waters, J. & Berntorp, E.; FENOC Study Group. (2007) A randomized comparison of bypassing agents in haemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood, 109, 546–551.
5. van den Berg, H.M., De Groot, P.H. & Fischer, K. (2007) Phenotypic heterogeneity in severe haemophilia. Journal of Thrombosis and Haemostasis, 5(Suppl. 1), 151–156.
6. Berntorp, E. (2009) Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors. Haemophilia, 15, 3–10.
7. Blasi, A., Beltran, J., Pereira, A., Martinez-Palli, G., Torrents, A., Balust, J., Zavala, E., Taura, P. & Garcia-Valdecasas, J.C. (2012) An assessment of thromboelastometry to monitor blood coagulation and guide transfusion support in liver transplantation. Transfusion, 52, 1989–1998.
8. Bolliger, D., Seeberger, M.D. & Tanaka, K.A. (2012) Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfusion Medicine Reviews, 26, 1–13.
9. Bolton-Maggs, P.H. (2013) The rare inherited coagulation disorders. Pediatric Blood Cancer, 60(Suppl. 1), S37–S40.
10. Bolton-Maggs, P.H. & Pasi, K.J. (2003) Haemophilias A and B. Lancet, 361, 1801–1809.
11. Brummel-Ziedins, K.E., Whelihan, M.F., Gissel, M., Mann, K.G. & Rivard, G.E. (2009) Thrombin generation and bleeding in haemophilia A. Haemophilia, 15, 1118–1125.
12. Chitlur, M., Warrier, I., Rajpurkar, M., Hollon, W., Llanto, L., Wiseman, C. & Lusher, J.M. (2008) Thromboelastography in children with coagulation factor deficiencies. British Journal of Haematology, 142, 250–256.
13. Chitlur, M., Sorensen, B., Rivard, G.E., Young, G., Ingerslev, J., Othman, M., Nugent, D., Kenet, G., Escobar, M. & Lusher, J. (2011) Standardization of thromboelastography: a report from the TEG-ROTEM working group. Haemophilia, 17, 532–537.
14. Chowdary, P., Lethagen, S., Friedrich, U., Brand, B., Hay, C., Abdul Karim, F., Klamroth, R., Knoebl, P., Laffan, M., Mahlangu, J., Miesbach, W., Dalsgaard Nielsen, J., Martín-Salces, M. & Angchaisuksiri, P. (2015) Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with haemophilia: a randomized first human dose trial. Journal of Thrombosis and Haemostasis, 13, 743–754.
15. Clevenger, B. & Mallett, S.V. (2014) Transfusion and coagulation management in liver transplantation. World Journal of Gastroenterology, 20, 6146–6158.
16. Coakley, M., Reddy, K., Mackie, I. & Mallett, S. (2006) Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. Journal of Cardiothoracic and Vascular Anesthesia, 20, 548–553.
17. Dargaud, Y., Lienhart, A., Meunier, S., Hequet, O., Chavanne, H., Chamouard, V., Marin, S. & Negrier, C. (2005) Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision. Haemophilia, 11, 552–558.
18. Dargaud, Y., Lienhart, A. & Negrier, C. (2010) Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in haemophilia patients with inhibitors undergoing elective surgery. Blood, 116, 5734–5737.
19. Davenport, R. (2013) Pathogenesis of acute traumatic coagulopathy. Transfusion, 53(Suppl. 1), 23S–27S.
20. Davenport, R., Manson, J., De'Ath, H., Platton, S., Coates, A., Allard, S., Hart, D., Pearse, R., Pasi, K.J., MacCallum, P., Stanworth, S. & Brohi, K. (2011) Functional definition and characterization of acute traumatic coagulopathy, Critical Care Medicine, 39, 2652–2658.
21. Dunning, J., Versteegh, M., Fabbri, A., Pavie, A., Kolh, P., Lockowandt, U., Nashef, S.A., Audit, E.A.C.T.S. & Committee, Guidelines (2008) Guideline on antiplatelet and anticoagulation management in cardiac surgery. European Journal of Cardio-Thoracic Surgery., 34, 73–92.
22. Furukawa, S., Nogami, K., Ogiwara, K., Yada, K., Minami, H. & Shima, M. (2015) Systematic monitoring of haemostatic management in haemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry. Journal of Thrombosis and Haemostasis, 13, 1279–1284.
23. Gilman, E.A., Koch, C.D., Santrach, P.J., Schears, G.J. & Karon, B.S. (2013) Fresh and citrated whole-blood specimens can produce different thromboelastography results in patients on extracorporeal membrane oxygenation. American Journal of Clinical Pathology, 140, 165–169.
24. Görlinger, K., Dirkmann, D., Hanke, A.A., Kamler, M., Kottenberg, E., Thielmann, M., Jakob, H. & Peters, J. (2011) First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology, 115, 1179–1191.
25. Görlinger, K., Dirkmann, D. & Hanke, A.A. (2013) Potential value of transfusion protocols in cardiac surgery. Current Opinion in Anaesthesiology, 26, 230–243.
26. Gu, J.M., Ramsey, P., Evans, V., Tang, L., Apeler, H., Leong, L., Murphy, J.E., Laux, V. & Myles, T. (2014) Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A. Haemophilia, 20, 593–600.
27. Hans, G.A. & Besser, M.W. (2016) The place of viscoelastic testing in clinical practice. British Journal of Haematology, 173, 37–48.
28. Hartert, H. (1948) Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungs verfahren. Klinische Wochenschrift, 26, 577–583.
29. Hayashi, T., Tanaka, I., Shima, M., Yoshida, K., Fukuda, K., Sakurai, Y., Matsumoto, T., Giddings, J.C. & Yoshioka, A. (2004) Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor. Haemophilia, 10, 397–400.
30. Hosokawa, K., Ohnishi, T., Kondo, T., Fukasawa, M., Koide, T., Maruyama, I. & Tanaka, K.A. (2011) A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions. Journal of Thrombosis and Haemostasis, 9, 2029–2037.
31. Hvas, A.M., Sørensen, H.T., Norengaard, L., Christiansen, K., Ingerslev, J. & Sørensen, B. (2007) Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe haemophilia A. Journal of Thrombosis and Haemostasis, 5, 2408–2414.
32. Jeger, V., Willi, S., Liu, T., Yeh, D.D., De Moya, M., Zimmermann, H. & Exadaktylos, A.K. (2012) The Rapid TEG α-Angle may be a sensitive predictor of transfusion in moderately injured blunt trauma patients. The Scientific World Journal, 2012, 821794.
33. Johansson, P.I. (2012) Coagulation monitoring of the bleeding traumatized patient. Current Opinion in Anaesthesiology, 25, 235–241.
34. Johansson, P.I. & Stensballe, J. (2009) Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sangguinis, 96, 111–118.
35. Kane, I., Ong, A., Orozco, F.R., Post, Z.D., Austin, L.S. & Radcliff, K.E. (2015) Thromboelastography predictive of death in trauma patients. Orthopaedic Surgery, 7, 26–30.
36. Kang, Y.G., Martin, D.J., Marquez, J., Lewis, J.H., Bontempo, F.A., Shaw, B.W. Jr, Starzl, T.E. & Winter, P.M. (1985) Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesthesia and Analgesia, 64, 888–896.
37. Kitazawa, T., Igawa, T., Sampei, Z., Muto, A., Kojima, T., Soeda, T., Yoshihashi, K., Okuyama-Nishida, Y., Saito, H., Tsunoda, H., Suzuki, T., Adachi, H., Miyazaki, T., Ishii, S., Kamata-Sakurai, M., Iida, T., Harada, A., Esaki, K., Funaki, M., Moriyama, C., Tanaka, E., Kikuchi, Y., Wakabayashi, T., Wada, M., Goto, M., Toyoda, T., Ueyama, A., Suzuki, S., Haraya, K., Tachibana, T., Kawabe, Y., Shima, M., Yoshioka, A. & Hattori, K. (2012) A bispecific antibody to factors IXa and X restores factor VIII haemostatic activity in a haemophilia A model. Nature Medicine, 18, 1570–1574.
38. Kitchen, D.P., Kitchen, S., Jennings, I., Woods, T. & Walker, I. (2010) Quality assurance and quality control of thrombelastography and rotational Thromboelastometry: the UK NEQAS for blood coagulation experience. Seminar in Thrombosis and Hemostasis, 36, 757–763.
39. Kundu, S.K., Heilmann, E.J., Sio, R., Garcia, C., Davidson, R.M. & Ostgaard, R.A. (1995) Description of an in vitro platelet function analyzer–PFA-100. Seminars in Thrombosis and Haemostasis, 21(Suppl. 2), 106–112.
40. Lak, M., Scharling, B., Blemings, A., Sharifian, R., Maleki, Z., Daraee, A., Arjmand, A.R. & Hedner, U. (2008) Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram. Haemophilia, 14, 103–110.
41. Lang, T., Bauters, A., Braun, S.L., Pötzsch, B., von Pape, K.W., Kolde, H.J. & Lakner, M. (2005) Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagulation and Fibrinolysis, 16, 301–310.
42. Larsen, O.H., Fenger-Eriksen, C., Christiansen, K., Ingerslev, J. & Sørensen, B. (2011) Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents. Anesthesiology, 115, 294–302.
43. Larsen, O.H., Fenger-Eriksen, C., Ingerslev, J. & Sørensen, B. (2012) Improved point-of-care identification of hyperfibrinolysis is needed. Thrombosis Research, 130, 690–691.
44. Leissinger, C., Gringeri, A., Antmen, B., Berntorp, E., Biasoli, C., Carpenter, S., Cortesi, P., Jo, H., Kavakli, K., Lassila, R., Morfini, M., Négrier, C., Rocino, A., Schramm, W., Serban, M., Uscatescu, M.V., Windyga, J., Zülfikar, B. & Mantovani, L. (2011) Anti-inhibitor coagulant complex prophylaxis in haemophilia with inhibitors. New England Journal of Medicine, 365, 1684–1692.
45. Lier, H., Vorweg, M., Hanke, A. & Görlinger, K. (2013) Thromboelastometry guided therapy of severe bleeding. Essener Runde algorithm. Hamostaseologie, 33, 51–61.
46. Mallett, S.V. (2015) Clinical Utility of Viscoelastic Tests of Coagulation (TEG/ROTEM) in Patients with Liver Disease and during Liver Transplantation. Seminar in Thrombosis and Hemostasis, 41, 527–537.
47. Mallett, S.V., Chowdary, P. & Burroughs, A.K. (2013) Clinical utility of viscoelastic tests of coagulation in patients with liver disease. Liver International, 33, 961–974.
48. NICE. (2014) Detecting, Monitoring, and Managing Haemostasis; Viscoelastometric Point-of-Care Testing (ROTEM, TEG, and Sonoclot Systems). NICE Diagnostics Guidance 13. 2014 National Institute for Health and Care Excellence, London.
49. Nielsen, V.G. (2007) A comparison of the Thrombelastograph and the ROTEM. Blood Coagulation & Fibrinolysis, 18, 247–252.
50. Nogami, K. & Shima, M. (2015) Phenotypic heterogeneity of haemostasis in severe haemophilia. Seminars in Thrombosis and Haemostasis, 41, 826–831.
51. Ogiwara, K., Nogami, K., Matsumoto, T. & Shima, M. (2014) Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe haemophilia A patients with inhibitor. International Journal of Hematology, 99, 577–587.
52. Ortmann, E., Rubino, A., Altemimi, B., Collier, T., Besser, M.W. & Klein, A.A. (2015) Validation of viscoelastic coagulation tests during cardiopulmonary bypass. Journal of Thrombosis and Haemostasis, 13, 1207–1216.
53. Oswald, E., Stalzer, B., Heitz, E., Weiss, M., Schmugge, M., Strasak, A., Innerhofer, P. & Haas, T. (2010) Thromboelastometry (ROTEM) in children: age-related reference ranges and correlations with standard coagulation tests. British Journal of Anaesthesia, 105, 827–835.
54. Owen, C.A. Jr, Rettke, S.R., Bowie, E.J., Cole, T.L., Jensen, C.C., Wiesner, R.H. & Krom, R.A. (1987) Hemostatic evaluation of patients undergoing liver transplantation. Mayo Clinic Proceedings, 62, 761–772.
55. Pipe, S.W. (2012) The hope and reality of long-acting haemophilia products. American Journal of Hematology, 87(Suppl. 1), S33–S39.
56. Raza, I., Davenport, R., Rourke, C., Platton, S., Manson, J., Spoors, C., Khan, S., De'Ath, H.D., Allard, S., Hart, D.P., Pasi, K.J., Hunt, B.J., Stanworth, S., MacCallum, P.K. & Brohi, K. (2013) The incidence and magnitude of fibrinolytic activation in trauma patients. Journal of Thrombosis and Haemostasis, 11, 307–314.
57. Rea, C.J., Foley, J.H., Ingerslev, J. & Sørensen, B. (2011) Factor XIII combined with recombinant factor VIIa: a new means of treating severe haemophilia A. Journal of Thrombosis and Haemostasis, 9, 510–516.
58. Riddell, A., Abdul-Kadir, R., Pollard, D., Tuddenham, E. & Gomez, K. (2011) Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery. Thrombosis and Haemostasis, 106, 521–527.
59. Roberts, I., Prieto-Merino, D. & Manno, D. (2014) Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial. Critical Care, 18, 685.
60. Roullet, S., Pillot, J., Freyburger, G., Biais, M., Quinart, A., Rault, A., Revel, P. & Sztark, F. (2010) Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation. British Journal of Anaesthesia., 104, 422–428.
61. Schöchl, H., Nienaber, U., Hofer, G., Voelckel, W., Jambor, C., Scharbert, G., Kozek-Langenecker, S. & Solomon, C. (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Critical Care, 14, R55.
62. Schramm, W., Royal, S., Kroner, B., Berntorp, E., Giangrande, P., Ludlam, C., Gringeri, A., Berger, K. & Szucs, T.; European haemophilia economic study group. (2002) Clinical outcomes and resource utilization associated with haemophilia care in Europe. Haemophilia, 8, 33–43.
63. Sehgal, A., Barros, S., Ivanciu, L., Cooley, B., Qin, J., Racie, T., Hettinger, J., Carioto, M., Jiang, Y., Brodsky, J., Prabhala, H., Zhang, X., Attarwala, H., Hutabarat, R., Foster, D., Milstein, S., Charisse, K., Kuchimanchi, S., Maier, M.A., Nechev, L., Kandasamy, P., Kel'in, A.V., Nair, J.K., Rajeev, K.G., Manoharan, M., Meyers, R., Sorensen, B., Simon, A.R., Dargaud, Y., Negrier, C., Camire, R.M. & Akinc, A. (2015) An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote haemostasis in haemophilia. Nature Medicine, 21, 492–497.
64. Shima, M., Matsumoto, T. & Ogiwara, K. (2008) New assays for monitoring haemophilia treatment. Haemophilia, 14(Suppl. 3), 83–92.
65. Sørensen, B. & Ingerslev, J. (2004) Whole blood clot formation phenotypes in haemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. Journal of Thrombosis and Haemostasis, 2, 102–110.
66. Sørensen, B. & Ingerslev, J. (2010) Platelet infusion supports recombinant factor VIIa in a patient with severe haemophilia A and inhibitor–clinical outcome and laboratory observations. Thrombosis and Haemostasis, 103, 1275–1276.
67. Sørensen, B. & Young, G. (2010) Global laboratory assays in haemophilia. In: Textbook of Haemophilia, 2nd edn. (eds. C. Lee, E. Berntorp & K. Hoots), pp. 263–268. Wiley-Blackwell, Oxford, UK.
68. ®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. Haemophilia, 18, 463–468.
69. Tauber, H., Innerhofer, P., Breitkopf, R., Westermann, I., Beer, R., El Attal, R., Strasak, A. & Mittermayr, M. (2011) Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the ‘Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study’. British Journal of Anaesthesia, 107, 378–387.
70. Theusinger, O.M., Wanner, G.A., Emmert, M.Y., Billeter, A., Eismon, J., Seifert, B., Simmen, H.P., Spahn, D.R. & Baulig, W. (2011) Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesthesia & Analgesia, 113, 1003–1012.
71. Tran, H.T., Sørensen, B., Bjørnsen, S., Pripp, A.H., Tjønnfjord, G.E. & Andre Holme, P. (2015) Monitoring bypassing agent therapy – a prospective crossover study comparing thromboelastometry and thrombin generation assay. Haemophilia, 21, 275–283.
72. Valentino, L.A., Allen, G., Gill, J.C., Hurlet, A., Konkle, B.A., Leissinger, C.A., Luchtman-Jones, L., Powell, J., Reding, M. & Stine, K. (2013) Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors. Haemophilia, 19, e151–e166.
73. Wang, S.C., Shieh, J.F., Chang, K.Y., Chu, Y.C., Liu, C.S., Loong, C.C., Chan, K.H., Mandell, S. & Tsou, M.Y. (2010) Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic livertransplantation: randomized clinical trial. Transplantation Proceedings., 42, 2590–2593.
74. Wasowicz, M., Srinivas, C., Meineri, M., Banks, B., McCluskey, S.A. & Karkouti, K. (2008) Technical report: analysis of citrated blood with thromboelastography: comparison with fresh blood samples. Canadian Journal of Anesthesia, 55, 284–289.
75. Waters, E.K., Hilden, I., Sørensen, B.B., Ezban, M. & Holm, P.K. (2015) Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive. Journal of Thrombosis and Haemostasis, 13, 2041–2052.
76. Weber, C.F., Görlinger, K., Meininger, D., Herrmann, E., Bingold, T., Moritz, A., Cohn, L.H. & Zacharowski, K. (2012) Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology, 117, 531–547.
77. White, G.C. 2nd, Rosendaal, F., Aledort, L.M., Lusher, J.M., Rothschild, C. & Ingerslev, J. (2001) Factor VIII and Factor IX Subcommittee. Definitions in haemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thrombosis and Haemostasis, 85, 560.
78. Whiting, D. & DiNardo, J.A. (2014) TEG and ROTEM: technology and clinical applications. American Journal of Hematology, 89, 228–232.
79. Wikkelsoe, A.J., Afshari, A., Wetterslev, J., Brok, J. & Moeller, A.M. (2011) Monitoring patients at risk of massive transfusion with Thrombelastography or Thromboelastometry: a systematic review. Acta Anaesthesiologica Scandinavica, 55, 1174–1189.
80. Yada, K., Nogami, K., Wakabayashi, H., Fay, P.J. & Shima, M. (2013) The mild phenotype in severe haemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X. Thrombosis and Haemostasis, 109, 1007–1015.
81. Yada, K., Kamiya, N., Shima, M. & Nogami, K. (2015a) A novel plasma-based factor Xa generation assay defines interaction between FVIIIa and each component of Xase complex in mild hemophilia A. Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. Journal of Thrombosis and Haemostasis 13(Suppl. 2), page 540, PO088.
82. Yada, K., Nogami, K., Shida, Y., Takeyama, M., Kasai, R. & Shima, M. (2015b) Enhanced global haemostatic potentials with a bispecific antibody to factor IXa and X (ACE910) in the whole blood by rotation thromboelastometry (ROTEM). Blood, 126, 3503.
83. Young, G., Blain, R., Nakagawa, P. & Nugent, D.J. (2006) Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography. Haemophilia, 12, 598–604.
84. Young, G., Sørensen, B., Dargaud, Y., Negrier, C., Brummel-Ziedins, K. & Key, N.S. (2013) Thrombin generation and whole blood viscoelastic assays in the management of haemophilia: current state of art and future perspectives. Blood, 121, 1944–1950.
85. Zia, A.N., Chitlur, M., Rajpurkar, M., Ozgonenel, B., Lusher, J., Callaghan, J.H. & Callaghan, M.U. (2015) Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotype. Haemophilia, 21, 124–132.